G Mycin Eye Drop
Prescription RequiredProduct introduction
G Mycin Eye Drop fights the infection by stopping the growth of bacteria. This helps to cure the underlying infection. Follow your doctor’s instructions precisely for administering this medicine in the eye. Wait for at least 5 minutes before applying any other eye medication. It should be used regularly at evenly spaced time intervals as prescribed by your doctor. Do not skip any doses and finish the full course of treatment even if you feel better. Stopping the medicine too early may lead to the infection returning or worsening.
It is a broad-spectrum type of antibiotic effective in killing many types of bacteria. However, it will not work for other types of eye infections (e.g., viral) and therefore, should only be used if prescribed by your doctor. Unnecessary use of any antibiotic can lead to a decrease in its effectiveness in the future.
Commonly seen side effects seen with this medicine include temporary eye irritation and burning sensation after administration. Consult your doctor if these side effects persist or if your condition worsens. It may cause some short-term blurring of vision when first used. Therefore, do not drive immediately after administering this medicine. Contact lenses should not be worn while you are using this medicine or while you have a bacterial eye infection.
Uses of G Mycin Eye Drop
- Treatment of Bacterial eye infections
Benefits of G Mycin Eye Drop
In Treatment of Bacterial eye infections
Side effects of G Mycin Eye Drop
Common side effects of G Mycin
- Application site irritation
- Burning sensation
How to use G Mycin Eye Drop
How G Mycin Eye Drop works
Safety advice
What if you forget to take G Mycin Eye Drop?
All substitutes
Quick tips
- You have been prescribed G Mycin Eye Drop for the treatment of bacterial infections of the eye.
- Do not skip any doses and finish the full course of treatment even if you feel better.
- Wait for at least 5-10 minutes before delivering the next medication in the same eye to avoid dilution.
- You should continue using the medicine for 48 hours after your symptoms have cleared up. However, do not use for longer than five days without consulting your doctor.
- It may cause short term blurring of vision when first used. Use caution before driving or using machines.
- Talk to your doctor if your symptoms haven't started to improve within two days of starting treatment, if they get worse during treatment, or if you get another eye infection.
- Do not wear contact lenses until your infection clears up.
- Throw away any medicine left at the end of the 5 day course.
Fact Box
Interaction with drugs
Patient concerns
FAQs
Is G Mycin Eye Drop effective?
I feel better now, can I stop using G Mycin Eye Drop?
What should I do if I forget to use G Mycin Eye Drop?
In which conditions is the use of G Mycin Eye Drop avoided?
What are the instructions for the storage and disposal of G Mycin Eye Drop?
Disclaimer:
Tata 1mg's sole intention is to ensure that its consumers get information that is expert-reviewed, accurate and trustworthy. However, the information contained herein should NOT be used as a substitute for the advice of a qualified physician. The information provided here is for informational purposes only. This may not cover everything about particular health conditions, lab tests, medicines, all possible side effects, drug interactions, warnings, alerts, etc. Please consult your doctor and discuss all your queries related to any disease or medicine. We intend to support, not replace, the doctor-patient relationship.References
- MacDougall C, Chambers HF. Aminoglycosides. In: Brunton LL, Chabner BA, Knollmann BC, editors. Goodman & Gilman’s: The Pharmacological Basis of Therapeutics. 12th ed. New York, New York: McGraw-Hill Medical; 2011. pp. 1515-16.
- Chambers HF, Deck DH. Aminoglycosides & Spectinomycin. In: Katzung BG, Masters SB, Trevor AJ, editors. Basic and Clinical Pharmacology. 11th ed. New Delhi, India: Tata McGraw Hill Education Private Limited; 2009. pp. 811-12.
- Briggs GG, Freeman RK, editors. A Reference Guide to Fetal and Neonatal Risk: Drugs in Pregnancy and Lactation. 10th ed. Philadelphia, PA: Wolters Kluwer Health; 2015. pp. 620-22.




